Brief: Biophytis SA Says Made Aware Of False Report Regarding Status Of Cova Study
13/04/2021 22:13
April 13 (Reuters) - Biophytis SA ALBPS.PA :
* BIOPHYTIS SA - HAS BEEN MADE AWARE OF A FALSE REPORT
REGARDING
STATUS OF ITS COVA STUDY OF ITS SARCONEOS (BIO101) TREATMENT IN
COVID-19 IN BRAZIL
* BIOPHYTIS SA - ON APRIL 12, 2021, AN ARTICLE WAS RELEASED
VIA
WBOC UNBEKNOWNST TO CO
Source text for Eikon: ID:nGNX5DzvYj
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon